Stay updated on Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.5.3 to v3.5.4, indicating a minor backend update. No clinical trial information or user-facing content is affected.
    Difference
    0.1%
    Check dated 2026-05-16T09:26:19.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    ClinicalTrials.gov updated the page’s software/version revision marker from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T05:28:54.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:49:08.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added the condition 'Inflammatory breast carcinoma' and the Genetic and Rare Diseases Information Center as a resources link. Updated revision labels from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-20T02:05:34.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T18:38:24.000Z thumbnail image
  9. Check
    109 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 on the page, a minor update with no changes to core study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:41:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.